Diabetes Pathophysiology: Pancreas, Insulin, Glucose Homeostasis & Types

Anatomy & Physiology of Glucose Regulation

Pancreas: Dual Function

  • Exocrine: Acinar cells → digestive enzymes (amylase, lipase, proteases) → duodenum.
  • Endocrine: Islets of Langerhans (1–2% pancreatic mass).
    • β-cells (65–80%): insulin + amylin.
    • α-cells (15–20%): glucagon.
    • δ-cells: somatostatin.
    • PP cells: pancreatic polypeptide.

Insulin Action

  • Binds receptor tyrosine kinase → IRS → PI3K/Akt → GLUT4 translocation (muscle, fat).
  • Suppresses hepatic gluconeogenesis/glycogenolysis.
  • Promotes lipogenesis, protein synthesis.
  • Half-life ~5–6 min; pulsatile secretion.

Glucose Homeostasis Loop

  1. Meal → glucose ↑ → β-cell depolarization (K_ATP closure) → Ca²⁺ influx → insulin exocytosis.
  2. Insulin → peripheral uptake + hepatic storage → glucose ↓.
  3. Glucose ↓ → α-cell glucagon ↑ → hepatic output ↑.

Diabetes Classification

TypePathophysiologyKey Features
T1DMAutoimmune β-cell destruction (T-cell mediated)Absolute insulin deficiency; ketoacidosis prone; HLA-DR3/DR4; GAD65, IA-2, ZnT8 Abs
T2DMInsulin resistance + progressive β-cell failureRelative deficiency; metabolic syndrome; polygenic; lifestyle-modifiable
GDMPlacental hormones (hPL, cortisol, progesterone) → insulin resistanceScreen 24–28 wk; ↑ future T2DM risk 7×; offspring metabolic programming
OtherMODY (monogenic), LADA (slow autoimmune), pancreatogenic (Type 3c), drug-inducedSpecific genetic/secondary causes

Management Pillars

  • Glucose monitoring (CGM preferred).
  • Medical nutrition therapy (carb consistency, fiber, healthy fats).
  • Physical activity (150 min aerobic + 2× resistance).
  • Pharmacotherapy: metformin first-line T2DM; insulin mandatory T1DM; GLP-1 RA, SGLT2i for cardiorenal benefit.
  • Complication screening (retina, nephro, neuro, vascular).

Diabetes - Related Articles